Study reveals gaps in interconception care for Australian mothers

Some Australian mothers regard navigating their personal health care in between pregnancies as confusing, inconsistent, and hard to access, new research by a Monash University-led team has found.

MindBio Therapeutics Completes World First Take Home Phase 2a Microdosing Depression Trial | Psychedelic Invest

VANCOUVER – MindBio Therapeutics Corp. (CSE: MBIO) (Frankfurt: WF6), (the ‘Company’ or ‘MindBio’), a leading biopharma company in psychiatric medicine development, is delighted to announce the completion of

February 15, 2024

A preview of Intra-Cellular Therapies’ depression drug, and sizing up the MASH opportunity

I am one week away from the launch of my weekly email newsletter! It’s called Adam’s Biotech Scorecard, and it’s exclusively for STAT subscribers. One

March 21, 2024

Nationwide Children’s Hospital pioneers new gene therapy for Duchenne muscular dystrophy

In a landmark moment for the Abigail Wexner Research Institute at Nationwide Children’s, a 5-year-old from Bellefontaine, Ohio, received the first dose of a recently

August 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.